Contract A207_PO-0450304-V3

Eurofins Genomics LLC has been awarded contract A207_PO-0450304-V3 by the University of Virginia, effective August 9, 2026, with a cumulative contract value of $52. The prime contractor will deliver four distinct synthetic oligonucleotide products, each specified with particular DNA sequences and salt-free formulations at 10-scale synthesis. The line items include S_FL_NPHS1_FD, NPHS1_HIS_S_RV, ov_his_cterm_fd, and ov_fl_nterm_rv sequences, with quantities ranging from 12 to 13 units per line item, each priced at $1 per unit.

The contract is executed in Virginia and specifies the University of Virginia as the delivery point and buyer. These synthetic oligonucleotides appear to support research activities, likely related to protein engineering or molecular biology applications based on the sequence characteristics and nomenclature. No specific contract period or annual value is delineated in the award documentation beyond the effective date of August 9, 2026. The modest cumulative value of $52 suggests this represents a small-scale research supply order rather than a comprehensive service engagement.